WYETH-AYERST COMMITS TO CHARACTERIZATION OF PREMARIN, FDA SAYS; GENERIC CONJUGATED ESTROGENS MAY NOT BE APPROVED UNTIL PREMARIN IS CHARACTERIZED

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".